Department of Medicine, Division of Digestive & Liver Diseases, Columbia University Irving Medical Center, New York, NY, USA; Department of Genetics & Development, Columbia University Irving Medical Center, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA; Digestive & Liver Diseases Research Center, Columbia University Irving Medical Center, New York, NY, USA.
Department of Medicine, Division of Digestive & Liver Diseases, Columbia University Irving Medical Center, New York, NY, USA; Department of Genetics & Development, Columbia University Irving Medical Center, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA; Digestive & Liver Diseases Research Center, Columbia University Irving Medical Center, New York, NY, USA; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA.
Cell. 2024 Jun 6;187(12):3039-3055.e14. doi: 10.1016/j.cell.2024.05.001.
In the prevailing model, Lgr5+ cells are the only intestinal stem cells (ISCs) that sustain homeostatic epithelial regeneration by upward migration of progeny through elusive upper crypt transit-amplifying (TA) intermediates. Here, we identify a proliferative upper crypt population marked by Fgfbp1, in the location of putative TA cells, that is transcriptionally distinct from Lgr5+ cells. Using a kinetic reporter for time-resolved fate mapping and Fgfbp1-CreER lineage tracing, we establish that Fgfbp1+ cells are multi-potent and give rise to Lgr5+ cells, consistent with their ISC function. Fgfbp1+ cells also sustain epithelial regeneration following Lgr5+ cell depletion. We demonstrate that FGFBP1, produced by the upper crypt cells, is an essential factor for crypt proliferation and epithelial homeostasis. Our findings support a model in which tissue regeneration originates from upper crypt Fgfbp1+ cells that generate progeny propagating bi-directionally along the crypt-villus axis and serve as a source of Lgr5+ cells in the crypt base.
在当前流行的模型中,Lgr5+ 细胞是唯一通过向上迁移通过难以捉摸的上隐窝过渡扩增(TA)中间产物的后代来维持稳态上皮再生的肠干细胞(ISC)。在这里,我们在假定的 TA 细胞位置鉴定了一个由 Fgfbp1 标记的增殖性上隐窝群体,其转录特征与 Lgr5+ 细胞明显不同。使用用于时间分辨命运映射的动力学报告基因和 Fgfbp1-CreER 谱系追踪,我们确定 Fgfbp1+ 细胞是多能的,并产生 Lgr5+ 细胞,这与它们的 ISC 功能一致。Fgfbp1+ 细胞在 Lgr5+ 细胞耗竭后也能维持上皮再生。我们证明了上隐窝细胞产生的 FGFBP1 是隐窝增殖和上皮稳态所必需的因素。我们的研究结果支持这样一种模型,即组织再生源自上隐窝 Fgfbp1+ 细胞,这些细胞沿着隐窝-绒毛轴双向产生后代,并作为隐窝底部 Lgr5+ 细胞的来源。